Resveratrol and Cardiovascular Health in the Elderly

  • STATUS
    Recruiting
  • End date
    Sep 1, 2022
  • participants needed
    300
  • sponsor
    National Institute on Aging (NIA)
Updated on 16 June 2021
cancer
stress test

Summary

Background
  • Resveratrol is a compound found in the skin of red grapes. It is being tested to see if it can have positive effects on human health. Lab studies show that it may help lower blood sugar, improve heart and blood vessel health, and prevent cancer. Researchers want to test different dose levels of Resveratrol to see what kind of effects it has on older overweight people. It will be tested in healthy volunteers at least 50 years of age.
    Objectives
  • To test the effects of different dose levels of Resveratrol on heart and blood vessel health.
    Eligibility
  • Healthy overweight nonsmoking volunteers at least 50 years of age.
    Design
  • This study will involve a screening visit and four study visits. Some of the study visits will involve overnight inpatient stays.
  • Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected. They will be given a list of foods that they should avoid eating while on the study.
  • Participants will be separated into three groups. Two groups will take different dose levels of the study drug. The third group will take a placebo.
  • At the first study visit, participants will stay in the clinical center overnight for 2 days of tests. They will provide blood and urine samples and have body scans to measure fat and muscle mass. They will also have exercise tests. A muscle biopsy will also be performed. At this visit, they will receive their dose of the study drug. They will continue to take this dose for as long as they are on the study.
  • The second visit will be 16 weeks after the first one. It will take only 2 hours, and repeat most of the tests from the screening visit.
  • The third visit will be 16 weeks later. It will involve an overnight stay. Most of the tests from the second visit will be repeated.
  • The fourth and final visit will be 16 weeks later. It will involve an overnight stay. Most of the tests from the initial study visit (including the scans and the exercise tests) will be repeated.

Description

Resveratrol is found in the leaves and skin of grapes, in peanuts and in the roots of the plant polygonum cupsidatum. Although used since early years in Indian Ayurvedic and Chinese medicine, it came into prominence in the 1990 s as it was believed to be the major reason for the positive effect of wine on cardiovascular health and the French Paradox. Since then, studies have shown that resveratrol affects a number of key cellular pathways and molecular targets with a wide range of biological effects. Noted among these are its effects on the blood vessels, cancer, blood clotting, blood sugar control, cognition, muscle activity and inflammation. Resveratrol also may produce some of the same effects as decreased food intake, perhaps through its action on a molecule in the body called Sirtuin, which is important because this is one of the only approaches that has consistently demonstrated beneficial effects on the aging process.

Resveratrol s action and pharmacology has been extensively studied in test tubes, cells, and animals but is only now being explored fully in people. The animal studies include a recent NIA-conducted study in monkeys that demonstrated a reduction in the stiffness of blood vessel over several weeks. Phase 1 and 2 clinical studies in healthy human volunteers or in patients with type II diabetes mellitus have begun to identify possible roles for resveratrol as a dietary supplement and the compound appears to have no harmful effects at doses up to 5 grams per day. There is also growing interest in pharmacological interventions targeting cardiovascular risk factors such as atherosclerosis and type II diabetes to prevent neurodegenerative diseases such as Alzheimer s disease (AD).

We will perform a 12-month trial of resVida (an oral preparation of resveratrol) in 120 randomized overweight/obese people over the age of 50 (40 in each group). This is a Phase 1 and 2 double-blind randomized study. One of two doses of study compound (75mg twice daily or 150mg twice daily) or placebo will be self-administered twice a day for 52 weeks to participants 50 years or older. The primary endpoint will be vascular stiffness (as measured by Pulse Wave Velocity) and the secondary endpoint will be exercise capacity as measured by oxygen utilization (VO2max). Testing will be done on the levels of resveratrol in the blood with different doses of the compound. The study will also include measurements of changes in blood glucose levels, inflammation, and exercise capacity. Targeted, quantitative metabolomics assays in blood will be performed to test whether concentrations of small metabolites previously shown to be associated with arterial stiffness, including free oxysterols, amino acids, acycarnitines and glycerophospholipids are modulated by resveratrol. These studies will provide necessary information for further testing of resVida as a compound that could promote healthy aging.

Details
Condition Senility, Antioxidants, Systemic Vascular Resistance, Vascular Diseases, Hypertension, Diabetes and Hypertension, High Blood Pressure (Hypertension), High Blood Pressure (Hypertension - Pediatric), Aerobic Capacity, Elevated Blood Pressure, Aging, high blood pressure, arterial hypertension
Treatment Placebo, Resveratrol
Clinical Study IdentifierNCT01842399
SponsorNational Institute on Aging (NIA)
Last Modified on16 June 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Male or Female, age 50 years or older
BMI greater than or equal to 25 or less than or equal to 35 and weight less
than 300 pounds
Participants must provide their own consent
Females must be menopausal or have had a bilateral oophorectomy
If over 55 years old: no menses for 12 months or longer. Women over 55 years old who haven't had a period for a year will be considered menopausal and do not need a FSH test
If 50-55 years old: no menses for 12 months AND an FSH level greater than or equal to 20\. Women between 50 and 55 years old who haven't had a period for a year, will need FSH test. If their FSH test is more than 20, they will be considered menopausal. If their FSH test is less than 20, they will not be eligible to participate

Exclusion Criteria

Liver Function Tests (LFT) greater than 2 times normal
Abnormal thyroid function, as evidenced by Free T3, t4, Free T4 or TSH +/- 5%
of the lab reference ranges
History of diabetes (gestational diabetes ok)
Hemoglobin A1C greater than 6.5 and/or fasating serum glucose greater than or
equal to 126 mg/dL
Renal dysfunction (GFR less than 60 mL/min)
Abnormal Coagulation profile (PT/PTT and INR)
Medications: (Due to potential interaction with resveratrol)
Cholesterol medications Atorvastatin(Lipitor) Rosuvastatin (Crestor)
Simvastatin (Zocor), Gemfibrazole (Lopid), Niacin (Niacor), etc
Aspirin greater than 81 mg
Taking medicines that may increase the risk of bleeding such as Coumadin (warfarin), Plavix (clopidogrel), Xarelto (rivaroxaban), Pradaxa (dabgatran), Eliquis (apixaban) or Heparin (blood thinning medications) due to their potential interaction with resveratrol and the increased risk for bleeding with the muscle biopsy
Taking supplements such as Ginkgo biloba, Ginseng or Ginger due to their increased risk of bleeding with the muscle biopsy
Chronic (daily) use of non-steroidal anti-inflammatory agents (NSAIDs) such as Motrin (Ibuprofen), Advil (Ibuprofen) or Naprosyn (Naproxen)-due to potential interaction with resveratrol. (Occasional use is ok if the participant does not take them 4 days before and 3 days after the muscle biopsy procedure)
Anti-diabetic medications: Insulin, Metformin (Glucophage, Avandamet
Glibomet, etc), Rosiglitazone (Avandia), Exenatide (Byetta), Sitagliptin
(Januvia), etc
Testosterone and estrogen supplement
Current glucocorticoid use, or up to 3 months ago (nasal, topical, ophthalmic
and inhaled use are not exclusionary)
Vitamin supplements containing resveratrol
Contraindications to MRI Study; e.g. metal implants, pacemakers, etc and hip
replacements (metal or plastic) due to inhibiting visualization of the area
Alcohol consumption more than 30 grams (equivalent to about 10 ounces of wine
being scanned
ounces of beer; 3 ounces of hard liquor) for men or 15 grams for women
Smoking nicotine presently or within the last 3 months
(equivalent to about 5 ounces of wine; 12 ounces of beer; 1.5 ounces of hard
liquor) daily
Known congestive heart failure now or in the past
Positive screening result for alcohol use at the screening visit. Score 8+ on
the AUDIT
Positive HIV, Hepatitis B or C testing
Positive urine drug test (exclusionary due to unknown interaction affect with
study medication and question of compliance with study procedures)
Benzodiazepines
Amphetamines
Barbiturates
Cannabis
Cocaine
Receipt of any investigational products (e.g. drugs, supplements, dietary
interventions) as part of a research study within 30 days of initial dose
administration
Unable to comply with the study requirements and procedures
Unable to perform treadmill testing due to reasons such as orthopedic
problems, moderate to severe aortic stenosis as found on echocardiogram at
ScreeningVisit, history of myocardial infarction in the last three months or
angina (under treatment)
Unable to perform knee strength testing due to reasons such as bilateral knee
replacements
Unable to perform hand grip testing due to any limitation such as pain or
deformity
Allergy or intolerance to local anesthetic- Lidocaine
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note